Pharming Group N.V.PHAR
那斯達克 · USD
13.50
+0.90
(+7.14%)
盤中 05/26 09:49 (UTC+8)
05/26 09:49 (UTC+8)
Pharming Group N.V.PHAR
13.50
+0.90
(+7.14%)
財務數據
損益表
- 0.81
- 0.56
- 0.74
- 0.75
- 927.00
- 0.79
- 0.93
- 0.97
- 1.07
- 0.72
- 21.84
- -31.56
- 33.29
- 1.02
- 123749.35
- -14.65
- 17.86
- 4.36
- 9.47
- -31.97
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 72,447 | 106,500 | 97,287 | 93,221 | 79,094 | 92,700,000 | 74,849 | 74,093 | 55,586 | 81,217 |
營業成本 | 6,644 | 21,100 | 7,071 | 8,972 | 8,323 | 12,200,000 | 6,819 | 7,981 | 8,386 | 7,118 |
營業毛利 | 65,803 | 85,400 | 90,216 | 84,249 | 70,771 | 80,500,000 | 68,030 | 66,112 | 47,200 | 74,099 |
營業費用 | 71,091 | 83,400 | 74,465 | 75,249 | 78,198 | 73,900,000 | 64,699 | 70,145 | 63,857 | 67,121 |
研發費用 | 25,557 | 32,100 | 23,384 | 23,695 | 21,142 | 22,300,000 | 20,721 | 21,597 | 18,521 | 11,627 |
推銷及管理費用 | 45,534 | 51,300 | 51,081 | 51,554 | 57,056 | 51,600,000 | 43,978 | 48,548 | 45,336 | -30,484 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | -777 | -912 | -345 | 99,633 |
營業利益 | -5,288 | 2,000 | 15,751 | 9,000 | -7,427 | 6,600,000 | 3,331 | -4,033 | -16,657 | 6,978 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 2,695 | 1,400 | 7,946 | 4 | 5,098 | - | 2,998 | 1,974 | 1,556 | 1,343 |
稅前純益 | -4,753 | 4,800 | 12,758 | 7,079 | -11,788 | 6,700,000 | 1,514 | -60 | -16,624 | -2,031 |
所得稅 | 459 | -500 | 5,209 | 2,529 | 3,100 | 3,800,000 | 2,548 | 1,158 | -4,176 | 1,092 |
稅後純益 | -5,213 | 5,300 | 7,548 | 4,694 | -14,719 | 2,900,000 | -1,034 | -1,218 | -12,448 | -3,123 |
基本每股稅後盈餘(元) | -0.07 | 0.08 | - | - | -0.22 | 0.04 | -0.02 | - | -0.19 | - |
稀釋每股稅後盈餘(元) | -0.07 | 0.07 | - | - | -0.22 | 0.04 | -0.02 | - | -0.19 | - |
基本平均股數(千股) | 74471.00 | 66250.00 | - | - | 66904.00 | 72500.00 | 51700.00 | - | 65515.00 | - |
稀釋平均股數(千股) | 74471.00 | 75714.00 | - | - | 66904.00 | 72500.00 | 51700.00 | - | 65515.00 | - |
還原基本每股稅後盈餘(元) | -0.07 | 0.08 | - | - | -0.22 | 0.04 | -0.02 | - | -0.19 | - |
還原稀釋每股稅後盈餘(元) | -0.07 | 0.07 | - | - | -0.22 | 0.04 | -0.02 | - | -0.19 | - |
還原基本平均股數(千股) | 74,471 | 66,250 | - | - | 66,904 | 72,500 | 51,700 | - | 65,515 | - |
還原稀釋平均股數(千股) | 74,471 | 75,714 | - | - | 66,904 | 72,500 | 51,700 | - | 65,515 | - |
EBITDA(千元) | 1,057 | 9,406 | 23,429 | 9,929 | -3,939 | 6,707,699 | 7,255 | 1,621 | -9,147 | 6,867 |